Agilent 1260 Infinity III Bio-Inert quaternary pump LC
Past New Requirement Updated
- Agency
-
Food and Drug Administration
Department of Health and Human Services
- Solicitation expected
- Estimated value
- $25,000 to $250,000
- Set-aside
- No set-aside
Forecast facts
- Anticipated award
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- Points of contact
-
- HFP Acquisition Liaison hfpacquisitions@fda.hhs.gov
Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.
About this forecast
The Food and Drug Administration is forecasting a new requirement for an Agilent 1260 Infinity III Bio-Inert quaternary pump LC system to replace existing liquid chromatography equipment used for toxic metals analysis. This analytical laboratory instrument is critical to maintaining the New York Health and Affiliated Facilities Laboratory's (NYHAFL) productivity in the Environmental Laboratory Element (ELE) Program Area Framework, as the current unit is no longer reliably operational. The solicitation is estimated to release on May 1, 2026, with an anticipated award date of September 1, 2026.
The estimated award value for this contract opportunity ranges from $25,000 to $250,000, with the procurement classified under NAICS code 334516 for analytical laboratory instrument manufacturing. This requirement falls under the Department of Health and Human Services and the Food and Drug Administration. For inquiries regarding this forecasted opportunity, interested contractors may contact the Acquisition Liaison at the FDA via email at hfpacquisitions@fda.hhs.gov.
Forecast text
Agilent 1260 Infinity III Bio-Inert quaternary pump LC
For the replacement of a liquid chromatography quaternary pump used for Toxic Metals analysis. The exisitng unit is no longer reliably operational and the need for a new unit is dire to continue NYHAFL's high productivity in the ELE PAF.
On GovTribe
Work this forecast
- Track it in your pipeline
- Find teaming partners
- Similar forecasts
- Ask GovTribe AI about this forecast